Skip to main content

Advertisement

Table 3 Complete blood count data of men (A) and women (B) before and following three weeks of supplementation with Ambrotose AO® at a dosage of 4 capsules per day and placebo (cross-over design with a three week washout between conditions).

From: Effect of Ambrotose AO® on resting and exercise-induced antioxidant capacity and oxidative stress in healthy adults

A         
Variable Trained Men Ambrotose AO® Pre Trained Men Ambrotose AO® Post Trained Men Placebo Pre Trained Men Placebo Post Untrained Men Ambrotose AO® Pre Untrained Men Ambrotose AO® Post Untrained Men Placebo Pre Untrained Men Placebo Post
WBC (103 μL)† 4.5 ± 0.1 4.5 ± 0.2 5.1 ± 0.6 4.9 ± 0.3 5.7 ± 0.5 6.0 ± 0.4 5.9 ± 0.5 5.6 ± 0.5
RBC (106 μL)* 4.9 ± 0.1 4.7 ± 0.1 4.9 ± 0.1 4.8 ± 0.1 4.7 ± 0.2 4.6 ± 0.2 4.6 ± 0.3 4.6 ± 0.2
Hemoglobin (g·dL-1)* 14.7 ± 0.3 13.3 ± 0.5 14.8 ± 0.4 14.6 ± 0.3 14.8 ± 0.5 14.6 ± 0.5 14.6 ± 0.6 14.4 ± 0.4
Hematocrit (%)†* 43.3 ± 0.8 41.8 ± 1.1 43.5 ± 1.0 42.3 ± 0.5 43.0 ± 1.0 41.9 ± 1.2 42.2 ± 2.0 41.2 ± 1.3
MCV (fL)** 88.7 ± 2.2 89.0 ± 2.5 88.3 ± 2.3 88.3 ± 2.2 91.2 ± 2.6 90.8 ± 2.3 91.6 ± 2.2 91.0 ± 2.5
MCH (pg)** 30.2 ± 1.0 30.5 ± 1.0 29.9 ± 1.0 30.3 ± 0.9 31.4 ± 1.0 31.7 ± 1.0 31.7 ± 1.0 31.9 ± 1.1
MCHC (g·dL-1)** 34.0 ± 0.4 34.2 ± 0.2 33.9 ± 0.4 34.4 ± 0.4 34.5 ± 0.4 34.9 ± 0.3 34.5 ± 0.3 35.0 ± 0.4
RDW (%)** 13.8 ± 0.4 13.2 ± 0.3 13.6 ± 0.3 13.5 ± 0.3 13.0 ± 0.2 13.1 ± 0.2 12.9 ± 0.2 12.9 ± 0.2
Platelets (103 μL)* 208.0 ± 16.7 204.0 ± 13.9 214.4 ± 16.1 211.4 ± 21.7 217.6 ± 20.4 203.2 ± 21.0 208.0 ± 24.5 209.6 ± 24.3
Neutrophils (%) 51.1 ± 4.5 50.0 ± 3.4 52.7 ± 4.9 51.0 ± 4.6 54.2 ± 2.6 58.0 ± 4.6 52.8 ± 2.1 53.6 ± 3.6
Lymphocytes (%) 36.0 ± 3.8 37.4 ± 3.2 36.0 ± 4.4 36.4 ± 4.3 32.6 ± 2.1 30.2 ± 4.1 34.2 ± 1.3 33.5 ± 2.9
Monocytes (%)† 7.7 ± 0.6 8.6 ± 0.8 7.6 ± 0.6 8.3 ± 0.5 7.4 ± 0.9 7.2 ± 1.2 7.0 ± 0.5 7.1 ± 0.9
Eosinophils (%)* 4.9 ± 1.8 3.7 ± 0.8 3.1 ± 0.7 3.9 ± 0.6 5.2 ± 1.6 4.0 ± 1.0 5.8 ± 1.8 5.3 ± 1.8
Basophils (%) 0.3 ± 0.2 0.3 ± 0.2 0.6 ± 0.2 0.4 ± 0.2 0.6 ± 0.2 0.6 ± 0.2 0.2 ± 0.2 0.5 ± 0.2
B         
Variable Trained Women Ambrotose AO ® Pre Trained Women Ambrotose AO ® Post Trained Women Placebo Pre Trained Women Placebo Post Untrained Women Ambrotose AO ® Pre Untrained Women Ambrotose AO ® Post Untrained Women Placebo Pre Untrained Women Placebo Post
WBC (103 μL)† 5.1 ± 1.0 5.2 ± 0.7 4.7 ± 0.4 5.3 ± 0.7 5.6 ± 0.5 4.9 ± 0.3 5.0 ± 0.4 6.0 ± 0.8
RBC (106 μL)* 4.2 ± 0.1 4.1 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 4.1 ± 0.1 4.2 ± 0.1 4.2 ± 0.2
Hemoglobin (g·dL-1)* 13.4 ± 0.4 12.8 ± 0.3 13.2 ± 0.1 13.2 ± 0.2 12.5 ± 0.3 12.1 ± 0.4 12.3 ± 0.5 12.4 ± 0.6
Hematocrit (%)†* 38.8 ± 1.0 37.1 ± 0.9 38.6 ± 0.4 37.9 ± 0.6 36.9 ± 0.8 35.0 ± 0.8 36.6 ± 1.4 36.5 ± 1.5
MCV (fL)** 91.9 ± 1.7 91.4 ± 1.8 91.4 ± 2.0 90.8 ± 2.0 87.1 ± 1.2 85.8 ± 0.7 86.5 ± 0.9 86.2 ± 0.9
MCH (pg)** 31.7 ± 0.7 31.6 ± 0.7 31.1 ± 0.7 31.5 ± 0.7 29.6 ± 0.4 29.7 ± 0.4 29.0 ± 0.4 29.3 ± 0.6
MCHC (g·dL-1)** 34.6 ± 0.2 34.6 ± 0.2 34.1 ± 0.2 34.7 ± 0.2 33.9 ± 0.2 34.6 ± 0.3 33.6 ± 0.2 33.9 ± 0.4
RDW (%)** 13.1 ± 0.3 13.3 ± 0.3 13.2 ± 0.2 13.5 ± 0.3 13.3 ± 0.5 13.6 ± 0.6 13.7 ± 0.6 13.7 ± 0.6
Platelets (103 μL)* 234.3 ± 20.0 229.1 ± 17.1 246.1 ± 23.6 236.1 ± 18.8 256.9 ± 29.9 259.2 ± 25.4 254.8 ± 35.6 267.0 ± 34.2
Neutrophils (%) 54.1 ± 5.5 56.3 ± 4.8 57.7 ± 4.7 58.8 ± 3.9 57.3 ± 3.5 56.0 ± 2.0 53.8 ± 3.2 58.3 ± 3.4
Lymphocytes (%) 34.3 ± 4.9 31.0 ± 4.0 30.6 ± 4.4 29.3 ± 3.2 34.3 ± 3.5 35.8 ± 1.8 36.5 ± 2.6 32.5 ± 3.0
Monocytes (%)† 8.0 ± 0.9 9.0 ± 1.0 7.3 ± 0.4 8.4 ± 0.6 6.1 ± 0.5 6.0 ± 0.5 6.2 ± 0.7 5.5 ± 0.8
Eosinophils (%)* 3.0 ± 0.5 3.3 ± 0.9 3.4 ± 0.6 3.0 ± 0.6 1.7 ± 0.5 1.8 ± 0.2 3.0 ± 0.6 2.7 ± 0.5
Basophils (%) 0.6 ± 0.2 0.4 ± 0.2 1.0 ± 0.0 0.5 ± 0.2 0.6 ± 0.2 0.3 ± 0.2 0.5 ± 0.2 0.5 ± 0.2
  1. Values are mean ± SEM.
  2. † Training status effect: WBC (p = 0.02); Hematocrit (p = 0.02); Monocytes (p = 0.0001)
  3. * Sex effect: RBC (p < 0.0001); Hemoglobin (p < 0.0001); Hematocrit (p < 0.0001); Platelets (p = 0.004); Eosinophils (p = 0.002)
  4. ** Sex × training status effect: MVC (p = 0.0002); MCH (p < 0.0001); MCHC (p = 0.008); RDW (p = 0.03)
  5. No other statistically significant differences were noted (p > 0.05).